Navigation Links
Stem cell research aims to tackle Parkinson's disease
Date:1/18/2008

Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinsons disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.

Professor Ernest Arenas of the Karolinska Institute in Stockholm presented his research to the EuroSTELLS Stem Cell Niches conference in Barcelona on January 11. Stem cell therapy hold the promise of treating disease by growing new tissues and organs from stem cells blank cells that have the potential to develop into fully mature or differentiated cells. The EuroSTELLS is an ESF EURCORES programme, managed by the European Medical Research Councils (EMRC), that aims to develop a stem cell toolbox by generating fundamental knowledge on stem cell biology.

Parkinsons disease affects around three in a hundred of people aged over 65. The condition can cause muscles to become rigid and limbs to tremble uncontrollably. Parkinsons disease results from the loss of a particular type of brain cell called dopaminergic (DA) neurons in the part of the brain called the substantia nigra.

Among the various approaches that are currently being discussed from an ethical perspective, is the possible approach of taking stem cells, growing them into new brain cells and transplanting these into the patient. The idea is to start with stem cells and induce them to become neurons, said Professor Arenas, whose research is carried out as part of a EuroSTELLS collaboration. These could then be transplanted into the brain of the patient. Also, such cells could be ideal for developing and testing new drugs to treat brain disease.

However, to create such cells that function efficiently and safely is a major challenge. Early efforts at growing DA neurons from embryonic stem cells produced cells which, when transplanted into animal models, had a tendency to form tumours or clumps, or die without an
'/>"/>

Contact: Dr. Fiona Kernan
fkernan@esf.org
33-388-762-180
European Science Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize
2. Researchers reveal HIV peptides possible pathway into the cell
3. Scientists call for urgent research into real impacts of invasive species
4. $13 million federal grant for research into vascular disease awarded to Weill Cornell
5. GM, Coskata partnership builds on Oklahoma State University biofuels research
6. USC researchers identify mechanism that controls activation of stem cells during hair regeneration
7. Researchers put the bite on mosquitoes
8. Montana State University researcher finds renewed interest in turning algae into fuel
9. Researchers find association between food insecurity and developmental risk in children
10. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
11. Japanese and German researchers meet to discuss climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015  For more than ... trade show has been the premier worldwide event for ... 2015 is a must-attend event for any local, national, ... into the emerging commercial markets and current applications of ... innovations of this projected $48 billion industry, and how ...
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... shipping to pre-order customers the first week of May, ... the month of May. Gino ... significant milestone for the company as Wocket® enters the ...
(Date:4/27/2015)... 27, 2015 Profile Solutions, Inc. (OTC: PSIQ), ... systems is pleased to announce that Dr Gerry ... and member of its scientific advisory board. ... a thought leader in technology-enhanced learning models. He was ... has published studies and books focused on online student ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... cells can grow new extensions when the amount of three ... , The research examined three related receptor proteins, called ... of rats. , When researchers increased the amount ... up to three times longer than those on nerve cells ...
... the detrimental loss of sea ice sheets in ... the scientific community have been saying for years. Now ... of Earth and Environmental Science are turning their attention to ... having similar effects in the frigid Antarctic region. ...
... tumor cells implanted in mice have shown that the ... breast cancer to the lungs. The new studies by ... genes work together to promote the growth of primary ... cancerous cells to escape into the bloodstream and penetrate ...
Cached Biology News:3 proteins may play important role in nerve-cell repair 2UTSA researchers examine effects of global warming on Antarctic 2A genetic 'gang of 4' drives spread of breast cancer 2A genetic 'gang of 4' drives spread of breast cancer 3A genetic 'gang of 4' drives spread of breast cancer 4
(Date:4/28/2015)... MA (PRWEB) April 28, 2015 ... (ACRES), a Massachusetts-based multi-stakeholder, non-profit organization dedicated to ... of a shared global system for clinical research, ... , an innovative new type of clinical research ... future of clinical research is changing,” said Greg ...
(Date:4/27/2015)... San Diego, Calif. (PRWEB) April 27, 2015 ... mechanisms of drug and chemical toxicity carries implications for ... featured speaker April 28 at National University , ... reception and presentation by Dr. Hanzlik, a professor at ... in drug metabolism and drug design, starts at 5 ...
(Date:4/27/2015)... Editor Note: For ... bottom . Investor-Edge has initiated coverage ... LXRX ), Idera Pharmaceuticals Inc. (NASDAQ: ... ), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI ), ... research report on Lexicon Pharma can be accessed ...
(Date:4/27/2015)... CAMBRIDGE, Massachusetts and HEIDELBERG ... Addresses unmet need in ... Molecular Health announced today it has been granted a patent ... Erythropoietin Receptor". This latest patent supports Molecular Health,s discovery that ... binds to EPO and promotes tumor growth. EPO stimulates the ...
Breaking Biology Technology:ACRES Announces Innovative Clinical Research Event--SYNERGY 2ACRES Announces Innovative Clinical Research Event--SYNERGY 3ACRES Announces Innovative Clinical Research Event--SYNERGY 4Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 2Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 3Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 4Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation 5Molecular Health Gains Patent for Novel Receptor Utilizing Computational Biomarker Discovery Technology 2
... Thompson, President,and CEO of Oncolytics Biotech Inc. (TSX: ... the Company at the BioSquare 2008 Conference on,Thursday, ... at the Congress Center in,Basel, Switzerland from March ... Oncolytics is a Calgary-based biotechnology company focused on ...
... Mass. and HEIDELBERG, Germany, March 10 febit,holding ... Ph.D., to,the newly created position of vice president, ... inc.,s U.S. headquarters, which is located near Boston ... marketing and sales initiatives for febit,s,genomics technology products ...
... - Anavex Life,Sciences Corp. ("ANAVEX") (OTCBB: AVXL) today ... significantly delay the growth of cancerous,tumors in patient-derived ... were developed in ANAVEX labs using a sample,taken ... Clear cell sarcoma,is a rare type of melanoma ...
Cached Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008 2febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales 2Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 2Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 3Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 4Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 5Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 6